Sangamo Therapeutics, Inc.
No trades
No trades
Compare with Sangamo Therapeutics, Inc.
−0.3829 USD
−122.93 M USD
39.55 M USD
410.43 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
Alexander D. Macrae
Website
Headquarters
Richmond
Founded
1995
IPO date
Apr 6, 2000
ISIN
US8006771062
CUSIP
800677106
FIGI
BBG000BHZ2P9
Identifiers
ISIN US8006771062
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The firm focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of SGMOQ is 0.0891 USD — it has increased by 3.36% in the past 24 hours. Watch Sangamo Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sangamo Therapeutics, Inc. stocks are traded under the ticker SGMOQ.
SGMOQ stock has risen by 39.22% compared to the previous week, the month change is a 56.32% rise, over the last year Sangamo Therapeutics, Inc. has showed a −84.29% decrease.
SGMOQ reached its all-time high on Sep 1, 2000 with the price of 51.3750 USD, and its all-time low was 0.0300 USD and was reached on Jun 25, 2026. View more price dynamics on SGMOQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SGMOQ stock is 15.12% volatile and has beta coefficient of 3.08. Track Sangamo Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sangamo Therapeutics, Inc. there?
Today Sangamo Therapeutics, Inc. has the market capitalization of 35.71 M, it has decreased by −10.96% over the last week.
Yes, you can track Sangamo Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Sangamo Therapeutics, Inc. is going to release the next earnings report on Aug 11, 2026. Keep track of upcoming events with our Earnings Calendar.
SGMOQ earnings for the last quarter are −0.08 USD per share, whereas the estimation was 0.01 USD resulting in a −1.70 K% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Sangamo Therapeutics, Inc. earnings.
Sangamo Therapeutics, Inc. revenue for the last quarter amounts to 1.44 M USD, despite the estimated figure of 33.73 M USD. In the next quarter, revenue is expected to reach 7.50 M USD.
SGMOQ net income for the last quarter is −31.00 M USD, while the quarter before that showed −37.42 M USD of net income which accounts for 0.00% change. Track more Sangamo Therapeutics, Inc. financial stats to get the full picture.
No, SGMOQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 5, 2026, the company has 142 employees. See our rating of the largest employees — is Sangamo Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sangamo Therapeutics, Inc. EBITDA is −104.32 M USD, and current EBITDA margin is −253.85%. See more stats in Sangamo Therapeutics, Inc. financial statements.
Like other stocks, SGMOQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sangamo Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sangamo Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sangamo Therapeutics, Inc. stock shows the sell signal. See more of Sangamo Therapeutics, Inc. technicals for a more comprehensive analysis.